BCL2 and B-cell chronic lymphocytic leukemia: In the last decade, the treatment landscape for CLL was revolutionized due to the establishment of both the critical role of the B-cell receptor (BCR) signaling pathway as well as the dependency of CLL cells on the anti-apoptotic protein Bcl-2.